{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:27:37Z","timestamp":1790044057897,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the 1\u20223\u20225 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["No. 2023HXFH034, 25HXJS035"],"award-info":[{"award-number":["No. 2023HXFH034, 25HXJS035"]}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"crossref","award":["No.2023NSFSC1484"],"award-info":[{"award-number":["No.2023NSFSC1484"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06535-3","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T05:50:18Z","timestamp":1756187418000},"page":"5935-5946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic value of dynamic minimal residual disease monitoring for adolescent and adult T-lymphoblastic leukemia\/lymphoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenggang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-6896","authenticated-orcid":false,"given":"Hongyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"4","key":"6535_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1470-2045(15)70082-3","volume":"16","author":"C-H Pui","year":"2015","unstructured":"Pui C-H, Pei D, Coustan-Smith E, Jeha S, Cheng C, Bowman WP, Sandlund JT, Ribeiro RC, Rubnitz JE, Inaba H, Bhojwani D, Gruber TA, Leung WH, Downing JR, Evans WE, Relling MV, Campana D (2015) Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Lancet Oncol 16(4):465\u2013474. https:\/\/doi.org\/10.1016\/S1470-2045(15)70082-3","journal-title":"Lancet Oncol"},{"issue":"2","key":"6535_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, Cheng C, Su X, Rubnitz JE, Basso G, Biondi A, Pui C-H, Downing JR, Campana D (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 10(2):147\u2013156. https:\/\/doi.org\/10.1016\/S1470-2045(08)70314-0","journal-title":"Lancet Oncol"},{"issue":"1","key":"6535_CR3","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1038\/bcj.2011.49","volume":"2","author":"M Neumann","year":"2012","unstructured":"Neumann M, Heesch S, G\u00f6kbuget N, Schwartz S, Schlee C, Benlasfer O, Farhadi-Sartangi N, Thibaut J, Burmeister T, Hoelzer D, Hofmann W-K, Thiel E, Baldus CD (2012) Clinical and molecular characterization of early T-Cell precursor leukemia: A high-Risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J 2(1):e55. https:\/\/doi.org\/10.1038\/bcj.2011.49","journal-title":"Blood Cancer J"},{"issue":"23","key":"6535_CR4","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1200\/JCO.2016.71.8585","volume":"35","author":"J Bond","year":"2017","unstructured":"Bond J, Graux C, Lhermitte L, Lara D, Cluzeau T, Leguay T, Cieslak A, Trinquand A, Pastoret C, Belhocine M, Spicuglia S, Lheritier V, Lepr\u00eatre S, Thomas X, Huguet F, Ifrah N, Dombret H, Macintyre E, Boissel N, Asnafi V (2017) Early response-based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic leukemia study. J Clin Oncol Off J Am Soc Clin Oncol 35(23):2683\u20132691. https:\/\/doi.org\/10.1200\/JCO.2016.71.8585","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"15","key":"6535_CR5","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","volume":"127","author":"N Jain","year":"2016","unstructured":"Jain N, Lamb AV, O\u2019Brien S, Ravandi F, Konopleva M, Jabbour E, Zuo Z, Jorgensen J, Lin P, Pierce S, Thomas D, Rytting M, Borthakur G, Kadia T, Cortes J, Kantarjian HM, Khoury JD (2016) Early T-Cell Precursor Acute Lymphoblastic Leukemia\/Lymphoma (ETP-ALL\/LBL)\u00a0in adolescents and adults: a High-Risk subtype. Blood 127(15):1863\u20131869. https:\/\/doi.org\/10.1182\/blood-2015-08-661702","journal-title":"Blood"},{"issue":"6","key":"6535_CR6","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/bjh.17424","volume":"193","author":"H Wang","year":"2021","unstructured":"Wang H, Zhou Y, Huang X, Zhang Y, Qian J, Li J, Li C, Li X, Lou Y, Zhu Q, Huang Y, Meng H, Yu W, Tong H, Jin J, Zhu H (2021) Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia. Br J Haematol 193(6):1096\u20131104","journal-title":"Br J Haematol"},{"key":"6535_CR7","doi-asserted-by":"publisher","first-page":"106627","DOI":"10.1016\/j.leukres.2021.106627","volume":"108","author":"S Yasuda","year":"2021","unstructured":"Yasuda S, Najima Y, Konishi T, Yamada Y, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Shingai N, Yoshioka K, Inamoto K, Mukae J, Toya T, Igarashi A, Shimizu H, Kobayashi T, Kakihana K, Sakamaki H, Kawamata N, Ohashi K (2021) Doki, N. Outcome of allogeneic hematopoietic stem cell transplantation for T-Cell lymphoblastic leukemia\/lymphoma: A Single-Center study. Leuk Res 108:106627. https:\/\/doi.org\/10.1016\/j.leukres.2021.106627","journal-title":"Leuk Res"},{"issue":"4","key":"6535_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41409-024-02211-8","volume":"59","author":"M Xiao","year":"2024","unstructured":"Xiao M, Zhou J, Zhu X, He Y, Wang F, Zhang Y, Mo X, Han W, Wang J, Wang Y, Chen H, Chen Y, Zhao X, Chang Y, Xu L, Liu K, Huang X, Zhang X (2024) A prognostic score system in adult T-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Bone Marrow Transplant 59(4):496\u2013504. https:\/\/doi.org\/10.1038\/s41409-024-02211-8","journal-title":"Bone Marrow Transplant"},{"issue":"24","key":"6535_CR9","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1182\/blood.2023020678","volume":"142","author":"BL Wood","year":"2023","unstructured":"Wood BL, Devidas M, Summers RJ, Chen Z, Asselin B, Rabin KR, Zweidler-McKay PA, Winick NJ, Borowitz MJ, Carroll WL, Raetz EA, Loh ML, Hunger SP, Dunsmore KP, Teachey DT, Winter SS (2023) Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a children\u2019s oncology group study. Blood 142(24):2069\u20132078. https:\/\/doi.org\/10.1182\/blood.2023020678","journal-title":"Blood"},{"key":"6535_CR10","doi-asserted-by":"publisher","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBDO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng W-J, Choi JK, Chuang S-S, Coupland SE, Czader M, Dave SS, De Jong D, Du M-Q, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li X-Q, Lim MS, Liu W-P, Louissaint A, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng S-B, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao (2022) W. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","DOI":"10.1038\/s41375-022-01620-2"},{"key":"6535_CR11","doi-asserted-by":"publisher","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng W-J, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile J-F, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li X-Q, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A (2022) The 5th Edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","DOI":"10.1038\/s41375-022-01613-1"},{"key":"6535_CR12","doi-asserted-by":"publisher","unstructured":"Das P, Kumar S, Ranjan R, Arumugam P, Dhole N, Kori RK, Yadav A, Singh A, Kanwar V, Singh N (2024) Should we perform baseline NGS Testing in precursor T lymphoblastic leukaemias: a single centre experience from Eastern India. ecancermedicalscience 18. https:\/\/doi.org\/10.3332\/ecancer.2024.1815","DOI":"10.3332\/ecancer.2024.1815"},{"issue":"5","key":"6535_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ajh.26144","volume":"96","author":"K Morita","year":"2021","unstructured":"Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, El Hussein S, Wang F, Short NJ, Maiti A, Sasaki K, Garcia-Manero G, Konoplev S, Ravandi F, Khoury JD, Jabbour E (2021) Outcome of T-cell acute lymphoblastic leukemia\/lymphoma: focus on near-ETP phenotype and differential impact of nelarabine. Am J Hematol 96(5):589\u2013598. https:\/\/doi.org\/10.1002\/ajh.26144","journal-title":"Am J Hematol"},{"issue":"20","key":"6535_CR14","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1182\/blood.2023021184","volume":"143","author":"RJ Hayashi","year":"2024","unstructured":"Hayashi RJ, Hermiston ML, Wood BL, Teachey DT, Devidas M, Chen Z, Annett RD, Asselin BL, August K, Cho S, Dunsmore KP, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju A, Lam A, Messinger YH, Miles RR, Okada M, Patel S, Schafer ES, Schechter T, Shimano KA, Singh N, Steele A, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay PA, Loh ML, Hunger SP, Raetz EA, Bollard CM, Allen CE (2024) MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: children\u2019s oncology group trial AALL1231. Blood 143(20):2053\u20132058. https:\/\/doi.org\/10.1182\/blood.2023021184","journal-title":"Blood"},{"issue":"8","key":"6535_CR15","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","volume":"118","author":"M Schrappe","year":"2011","unstructured":"Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Gr\u00fcmayer R, M\u00f6ricke A, Parasole R, Zimmermann M, Dworzak M, Buldini B, Reiter A, Basso G, Klingebiel T, Messina C, Ratei R, Cazzaniga G, Koehler R, Locatelli F, Sch\u00e4fer BW, Aric\u00f2 M, Welte K, van Dongen JJM, Gadner H, Biondi A, Conter V (2011) Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood 118(8):2077\u20132084. https:\/\/doi.org\/10.1182\/blood-2011-03-338707","journal-title":"Blood"},{"issue":"1","key":"6535_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/16078454.2019.1567654","volume":"24","author":"N G\u00f6kbuget","year":"2019","unstructured":"G\u00f6kbuget N, Dombret H, Giebel S, Bruggemann M, Doubek M, Fo\u00e0 R, Hoelzer D, Kim C, Martinelli G, Parovichnikova E, Rambaldi A, Ribera J-M, Schoonen M, Stieglmaier JM, Zugmaier G, Bassan R (2019) Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia. Hematology 24(1):337\u2013348. https:\/\/doi.org\/10.1080\/16078454.2019.1567654","journal-title":"Hematology"},{"issue":"12","key":"6535_CR17","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3324\/haematol.10882","volume":"92","author":"M Hunault","year":"2007","unstructured":"Hunault M, Truchan-Graczyk M, Caillot D, Harousseau J-L, Bologna S, Himberlin C, Guyotat D, Berthou C, Casassus P, Baranger L, B\u00e9n\u00e9 M-C, Ifrah N, Gyan E (2007) GOELAMS group. Outcome of adult T-Lymphoblastic lymphoma after acute lymphoblastic Leukemia-Type treatment: A GOELAMS trial. Haematologica 92(12):1623\u20131630. https:\/\/doi.org\/10.3324\/haematol.10882","journal-title":"Haematologica"},{"issue":"6","key":"6535_CR18","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00277-024-05719-7","volume":"103","author":"L Luo","year":"2024","unstructured":"Luo L, Jiao Y, Li Y, Yang P, Gao J, Huang S, Huang W, Wang J, Dong F, Ke X, Zou D, Gao C, Jing H (2024) Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult tlymphoblastic leukemia \/lymphoma: a large cohort multicenter study in China. Ann Hematol 103(6):2073\u20132087. https:\/\/doi.org\/10.1007\/s00277-024-05719-7","journal-title":"Ann Hematol"},{"issue":"19","key":"6535_CR19","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1200\/JCO.21.02678","volume":"40","author":"DT Teachey","year":"2022","unstructured":"Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA (2022) Children\u2019s oncology group trial AALL1231: A phase III clinical trial testing bortezomib in newly diagnosed T-Cell acute lymphoblastic leukemia and lymphoma. J Clin Oncol 40(19):2106\u20132118. https:\/\/doi.org\/10.1200\/JCO.21.02678","journal-title":"J Clin Oncol"},{"issue":"20","key":"6535_CR20","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"1","key":"6535_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ajh.24947","volume":"93","author":"Y Abaza","year":"2018","unstructured":"Abaza Y, Kantarjian M, Faderl H, Jabbour S, Jain E, Thomas N, Kadia D, Borthakur T, D Khoury G, Burger J, Wierda J, O\u2019Brien W, Konopleva S, Ferrajoli M, Kebriaei A, Dabaja P, Kornblau B, Alvarado S, Daver Y, Pemmaraju N, Bose N, Thompson P, Al P, Azzawi H, Kelly M, Garris R, Jain P, Garcia-Manero G, Cortes J, Ravandi F (2018) Hyper-CVAD plus nelarabine in newly diagnosed adult T-Cell acute lymphoblastic leukemia and T-Lymphoblastic lymphoma. Am J Hematol 93(1):91\u201399. https:\/\/doi.org\/10.1002\/ajh.24947","journal-title":"Am J Hematol"},{"issue":"8027","key":"6535_CR22","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","volume":"632","author":"P P\u00f6l\u00f6nen","year":"2024","unstructured":"P\u00f6l\u00f6nen P, Di Giacomo D, Seffernick AE, Elsayed A, Kimura S, Benini F, Montefiori LE, Wood BL, Xu J, Chen C, Cheng Z, Newman H, Myers J, Iacobucci I, Li E, Sussman J, Hedges D, Hui Y, Diorio C, Uppuluri L, Frank D, Fan Y, Chang Y, Meshinchi S, Ries R, Shraim R, Li A, Bernt KM, Devidas M, Winter SS, Dunsmore KP, Inaba H, Carroll WL, Ramirez NC, Phillips AH, Kriwacki RW, Yang JJ, Vincent TL, Zhao Y, Ghate PS, Wang J, Reilly C, Zhou X, Sanders MA, Takita J, Kato M, Takasugi N, Chang BH, Press RD, Loh M, Rampersaud E, Raetz E, Hunger SP, Tan K, Chang T-C, Wu G, Pounds SB, Mullighan CG (2024) Teachey, D. T. The genomic basis of childhood T-Lineage acute lymphoblastic leukaemia. Nature 632(8027):1082\u20131091. https:\/\/doi.org\/10.1038\/s41586-024-07807-0","journal-title":"Nature"},{"issue":"8","key":"6535_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.6004\/jnccn.2024.0051","volume":"22","author":"B Shah","year":"2024","unstructured":"Shah B, Mattison RJ, Abboud R, Abdelmessieh P, Aldoss I, Burke PW, DeAngelo DJ, Dinner S, Fathi AT, Gauthier J, Haddadin M, Jain N, Jonas B, Kirby S, Liedtke M, Litzow M, Logan A, Long M, Luger S, Mangan JK, Massaro S, May W, Oluwole O, Park J, Przespolewski A, Rangaraju S, Saygin C, Schwartz M, Shami P, Tomlinson B, Webster J, Awotiwon A, Stehman K (2024) Acute lymphoblastic leukemia, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22(8):563\u2013576. https:\/\/doi.org\/10.6004\/jnccn.2024.0051","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"6535_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/cyto.b.21939","volume":"100","author":"PR Tembhare","year":"2021","unstructured":"Tembhare PR, Chatterjee G, Khanka T, Ghogale S, Badrinath Y, Deshpande N, Panda D, Patkar NV, Narula G, Girase K, Verma S, Sanyal M, Sriram HN, Banavali S, Gujral S, Subramanian PG (2021) Eleven-marker 10\u2010color flow cytometric assessment of measurable residual disease for T\u2010cell acute lymphoblastic leukemia using an approach of exclusion. Cytometry B Clin Cytom 100(4):421\u2013433. https:\/\/doi.org\/10.1002\/cyto.b.21939","journal-title":"Cytometry B Clin Cytom"},{"issue":"6","key":"6535_CR25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1200\/JCO.20.02333","volume":"39","author":"J Stutterheim","year":"2021","unstructured":"Stutterheim J, van der Sluis IM, de Lorenzo P, Alten J, Ancliffe P, Attarbaschi A, Brethon B, Biondi A, Campbell M, Cazzaniga G, Escherich G, Ferster A, Kotecha RS, Lausen B, Li CK, Lo Nigro L, Locatelli F, Marschalek R, Meyer C, Schrappe M, Stary J, Vora A, Zuna J, van der Velden VHJ, Szczepanski T, Valsecchi MG, Pieters R (2021) Clinical implications of minimal residual disease detection in infants with KMT2A-rearranged acute lymphoblastic leukemia treated on the Interfant-06 protocol. J Clin Oncol 39(6):652\u2013662. https:\/\/doi.org\/10.1200\/JCO.20.02333","journal-title":"J Clin Oncol"},{"issue":"7","key":"6535_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3760\/cma.j.issn.0253-2727.2019.07.005","volume":"40","author":"HY Liao","year":"2019","unstructured":"Liao HY, Sun ZY, Wang YX, Jin YM, Zhu HL, Jiang NG (2019) [Outcome of 126 adolescent and adult T-cell acute leukemia\/lymphoma patients and the prognostic significance of early T-cell precursor leukemia subtype]. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi 40(7):561\u2013567. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2019.07.005","journal-title":"Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi"},{"issue":"3","key":"6535_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5045\/br.2022.2022104","volume":"57","author":"K Bommannan","year":"2022","unstructured":"Bommannan K, Arumugam JR, Radhakrishnan V, Kalaiyarasi JP, Karunakaran P, Mehra N, Sagar TG, Sundersingh S (2022) Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients. Blood Res 57(3):175\u2013196. https:\/\/doi.org\/10.5045\/br.2022.2022104","journal-title":"Blood Res"},{"key":"6535_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611710","author":"M Zhang","year":"2020","unstructured":"Zhang M, Huang H (2020) How to combine the two landmark treatment methods\u2014allogeneic hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy together to cure high-risk B cell acute lymphoblastic leukemia?? Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.611710","journal-title":"Front Immunol"},{"issue":"3","key":"6535_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11596-021-2390-6","volume":"41","author":"Z Wang","year":"2021","unstructured":"Wang Z, Wang Y, Xu L, Zhang X, Wang Y, Chen H, Chen Y, Wang F, Han W, Sun Y, Yan C, Tang F, Mo X, Wang Y, Liu Y, Liu K, Huang X, Chang Y (2021) Predictive value of dynamic peri-transplantation MRD assessed by MFC either alone or in combination with other variables for outcomes of patients with T-cell acute lymphoblastic leukemia. Curr Med Sci 41(3):443\u2013453. https:\/\/doi.org\/10.1007\/s11596-021-2390-6","journal-title":"Curr Med Sci"},{"issue":"6","key":"6535_CR30","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41375-018-0307-6","volume":"33","author":"S Modvig","year":"2019","unstructured":"Modvig S, Madsen HO, Siitonen SM, Rosth\u00f8j S, Tierens A, Juvonen V, Osnes LTN, V\u00e5lerhaugen H, Hultdin M, Th\u00f6rn I, Matuzeviciene R, Stoskus M, Marincevic M, Fogelstrand L, Lilleorg A, Toft N, J\u00f3nsson OG, Pruunsild K, Vaitkeviciene G, Vettenranta K, Lund B, Abrahamsson J, Schmiegelow K, Marquart HV (2019) Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia. Leukemia 33(6):1324\u20131336. https:\/\/doi.org\/10.1038\/s41375-018-0307-6","journal-title":"Leukemia"},{"issue":"21","key":"6535_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V124.21.1.1","volume":"124","author":"BL Wood","year":"2014","unstructured":"Wood BL, Winter SS, Dunsmore KP, Devidas M, Chen S, Asselin B, Esiashvili N, Loh ML, Winick NJ, Carroll WL, Raetz EA, Hunger SP (2014) T-lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of significance of the early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of End-Induction minimal residual disease (MRD) in children\u2019s oncology group (COG) study AALL0434. Blood 124(21):1. https:\/\/doi.org\/10.1182\/blood.V124.21.1.1","journal-title":"Blood"},{"issue":"9","key":"6535_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","volume":"19","author":"PA Brown","year":"2021","unstructured":"Brown PA, Shah B, Advani A, Aoun P, Boyer MW, Burke PW, DeAngelo DJ, Dinner S, Fathi AT, Gauthier J, Jain N, Kirby S, Liedtke M, Litzow M, Logan A, Luger S, Maness LJ, Massaro S, Mattison RJ, May W, Oluwole O, Park J, Przespolewski A, Rangaraju S, Rubnitz JE, Uy GL, Vusirikala M, Wieduwilt M, Lynn B, Berardi RA, Freedman-Cass DA, Campbell M (2021) Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19(9):1079\u20131109. https:\/\/doi.org\/10.6004\/jnccn.2021.0042","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"6535_CR33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/bjh.15086","volume":"180","author":"F Lovisa","year":"2018","unstructured":"Lovisa F, Zecca M, Rossi B, Campeggio M, Magrin E, Giarin E, Buldini B, Songia S, Cazzaniga G, Mina T, Acquafredda G, Quarello P, Locatelli F, Fagioli F, Basso G (2018) Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia. Br J Haematol 180(5):680\u2013693. https:\/\/doi.org\/10.1111\/bjh.15086","journal-title":"Br J Haematol"},{"issue":"1","key":"6535_CR34","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1038\/s41598-025-91936-7","volume":"15","author":"AP de Azambuja","year":"2025","unstructured":"de Azambuja AP, Beltrame MP, Malvezzi M, Schluga YC, Justus JLP, Lima ACM, Funke VAM, Bonfim C, Pasquini R (2025) Impact of high-sensitivity flow cytometry on peri-transplant minimal residual disease kinetics in acute leukemia. Sci Rep 15(1):6942. https:\/\/doi.org\/10.1038\/s41598-025-91936-7","journal-title":"Sci Rep"},{"issue":"1","key":"6535_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-0609.2010.01522.x","volume":"86","author":"G Vaitkevi\u010dien\u0117","year":"2011","unstructured":"Vaitkevi\u010dien\u0117 G, Forestier E, Hellebostad M, Heyman M, Jonsson OG, L\u00e4hteenm\u00e4ki PM, Rosthoej S, S\u00f6derh\u00e4ll S, Schmiegelow K (2011) Nordic society of paediatric haematology and oncology (NOPHO). High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. Eur J Haematol 86(1):38\u201346. https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01522.x","journal-title":"Eur J Haematol"},{"issue":"4","key":"6535_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1182\/blood.2020010438","volume":"138","author":"J Tang","year":"2021","unstructured":"Tang J, Yu J, Cai J, Zhang L, Hu S, Gao J, Jiang H, Fang Y, Liang C, Ju X, Jin R, Zhai X, Wu X, Tian X, Hu Q, Wang N, Jiang H, Sun L, Leung AWK, Yang M, Pan K, Cheng C, Zhu Y, Zhang H, Li C, Yang JJ, Li C-K, Zhu X, Shen S, Pui C-H (2021) Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation. Blood 138(4):331\u2013343. https:\/\/doi.org\/10.1182\/blood.2020010438","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1007\/s00277-025-06665-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06535-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06535-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06535-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:31:18Z","timestamp":1764729078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06535-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6535"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06535-3","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00277-025-06665-8","URL":"https:\/\/doi.org\/10.1007\/s00277-025-06665-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All included subjects signed an informed consent form. The study protocol was in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of West China Hospital of Sichuan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}